ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : -34 مورد

Drugs associated with increased risk of adverse effects in patients with heart failure

Drugs associated with increased risk of adverse effects in patients with heart failure
Drug/drug class Adverse effect(s)
Anti-inflammatory medications
Glucocorticoids Sodium retention (particularly with fludrocortisone, hydrocortisone)
NSAIDs Sodium retention and peripheral vasocontriction; blunted response to diuretics and angiotensin converting enzyme inhibitors
Cardiovascular medications
Class I antiarrhythmic agents* Negative inotropy; proarrhythmia; increased mortality with IA and IC agents in post-MI trials
Class III antiarrhythmic agents (included sotalol and ibutalide)* Proarrhythmia
Calcium channel blockers (other than amlodipine or felodipine)* Negative inotropy; neurohumoral activation
Minoxidil* Sodium retention; neurohumoral activation
Diabetes medications
Metformin Lactic acidosis
Thiazolidinediones Sodium retention
Phosphdiesterase inhibitors
Anagrelide Palpitations; tachycardia; sodium retention; induction or exacerbation of HF
Cilostazol Ventricular tachyarrhythmias
Neurologic and psychiatric medications
Amphetamines* Sympathetic agonist activity; hypertension; tachycardia; tachyarrhythmias
Carbamazepine Negative inotropic effect; bradyarrhythmias
Clozapine Development of myocarditis and cardiomyopathy
Ergot alkaloids (ergotamine, dihydroergotamine) Sympathetic agonist activity; valve fibrosis
Pergolide (not available in the US) Valve fibrosis
Tricyclic antidepressants Negative inotropic effect; proarrhythmia
Miscellaneous
Beta-2 agonists Sympathetic agonist activity; tachyarrhythmias; hypokalemia
Trimethoprim-sulfamethoxazole Risk of hyperkalemia or acute kidney injury when taken with ACE inhibitor or ARB
Risk of hyperkalemia when taken with MRA
Itraconazole Negative inotropic effect; also can increase serum digoxin concentrations
Licorice Mineralocorticoid excess: sodium retention and hypokalemia
Sodium-containing preparations (eg, Fleet PhosPho soda)  
Sodium load QT-prolonging drugs (eg, haloperidol, erythromycin) Proarrhythmia
NSAIDs: nonsteroidal anti-inflammatory drugs; MI: myocardial infarction; HF: heart failure; ACE: angiotensin-converting enzyme; ARB: angiotension II receptor blockers; MRA: mineralocorticoid receptor antagonist.
* Evidence from randomized placebo controlled trials.
¶ Increased risk noted in American College of Cardiology/American Heart Association heart failure guidelines (Hunt SA, et al. Circulation 2005; 112:e154.).
Data modified from Amabile CM, Spencer AP. Arch Intern Med 2004; 164:709.
Graphic 68838 Version 6.0